By Business/Source
Currency:USD
2026/FY
Stock NameRevenueRatio
Pocono Pharmaceuticals2.04M100.00%
By Country/Region
Currency:USD
2026/FY
Stock NameRevenueRatio
United States2.03M99.63%
Outside the United States7.63K0.37%